- 全部删除
您的购物车当前为空
EGFR-IN-11 是 EGFR-酪氨酸激酶的选择性抑制剂,可诱导细胞凋亡。 EGFR-IN-11 抑制三重突变体 EGFRL858R/T790M/C797S,IC50 为 18 nM,并在 G0/G1 时阻止细胞周期。


为众多的药物研发团队赋能,
让新药发现更简单!
EGFR-IN-11 是 EGFR-酪氨酸激酶的选择性抑制剂,可诱导细胞凋亡。 EGFR-IN-11 抑制三重突变体 EGFRL858R/T790M/C797S,IC50 为 18 nM,并在 G0/G1 时阻止细胞周期。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 330 | In stock | |
| 5 mg | ¥ 805 | In stock | |
| 10 mg | ¥ 1,180 | In stock | |
| 25 mg | ¥ 1,880 | In stock | |
| 50 mg | ¥ 2,480 | In stock | |
| 100 mg | ¥ 3,420 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,020 | In stock |
EGFR-IN-11 相关产品
| 产品描述 | EGFR-IN-11 is a selective inhibitor of EGFR-tyrosine kinase and induces cell apoptosis. EGFR-IN-11 inhibits triple mutant EGFRL858R/T790M/C797S with an IC50 of 18 nM and arrests cell cycle at G0/G1. |
| 靶点活性 | EGFR (L858R/T790M/C797S):18 nM |
| 体外活性 | EGFR-IN-11 (0.1 nM-10 µM) 对HCC827、H1975和A549细胞表现出抗增殖作用,IC50分别为0.88 nM、0.20 µM和2.91 μM。在浓度依赖性的条件下,EGFR-IN-11 (10nM-10 µM) 在HCC827、H1975和A549细胞中抑制了EGFR的磷酸化[1]。 |
| 分子量 | 573.71 |
| 分子式 | C29H35N9O2S |
| CAS No. | 2463200-44-2 |
| Smiles | CN1CCN(CC1)c1ccc(Nc2ncc3nc(Nc4ccccc4)n([C@@H]4CCN(C4)S(=O)(=O)C4CC4)c3n2)cc1 |
| 密度 | 1.48 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 112.5 mg/mL (196.1 mM ), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4 mg/mL (6.97 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容